Pharmaceutical Commerce - March 2020
Dramatic growth tracks the flood of new specialty pharmaceuticals entering the market
ICER will expand use of RWE, as the Federal ONC calls for broader use of healthcare data
Clarivate Analytics predicts both approvals and commercial potential
A former executive at PhRMA, Davis will now lead the wholesaler-distributor association
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
BoomRx Expands Access to Oral Semaglutide and Tirzepatide Using Nanoemulsion Delivery
2
The Hidden Economics of Health Insurance Affordability
3
Pharma Pulse: Novartis Warns of Trade Fragmentation; Hospital M&A Hits Record Low; Copay Shock Warning
4
Evaluate’s 2026 Pharma Forecast Signals Cautious Recovery, Rising M&A, and GLP-1 Market Shifts
5